Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J DeKernion

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Urology|May 1, 1989
Intravesical bacillus Calmette-Guérin and second primary malignanciesP Guinan, S Brosman, J DeKernion, et al.
The Journal of Urology|September 1, 1997
Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumorR A Figlin, W C Pierce, R Kaboo, et al.
Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.
Urology|March 1, 1995
Treatment with finasteride following radical prostatectomy for prostate cancerG Andriole, M Lieber, J Smith, et al.
The Journal of Urology|November 1, 1993
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinomaA Belldegrun, W Pierce, R Kaboo, et al.
Cancer Research|October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step processN Craft, C Chhor, C Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinomaA Hinkel, C L Tso, B J Gitlitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacyP J Rosen, E F Mendoza, E M Landaw, et al.
The Journal of Urology|November 1, 1996
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patientsM H Sokoloff, C L Tso, R Kaboo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccinesP Mulders, C L Tso, B Gitlitz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Urology|May 1, 1989
Intravesical bacillus Calmette-Guérin and second primary malignanciesP Guinan, S Brosman, J DeKernion, et al.
The Journal of Urology|September 1, 1997
Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumorR A Figlin, W C Pierce, R Kaboo, et al.
Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.
Urology|March 1, 1995
Treatment with finasteride following radical prostatectomy for prostate cancerG Andriole, M Lieber, J Smith, et al.
The Journal of Urology|November 1, 1993
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinomaA Belldegrun, W Pierce, R Kaboo, et al.
Cancer Research|October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step processN Craft, C Chhor, C Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinomaA Hinkel, C L Tso, B J Gitlitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacyP J Rosen, E F Mendoza, E M Landaw, et al.
The Journal of Urology|November 1, 1996
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patientsM H Sokoloff, C L Tso, R Kaboo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccinesP Mulders, C L Tso, B Gitlitz, et al.
Pageof 3